Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norma Rogers

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental Hematology|December 14, 2004
Control of rHuEPO biological activity: the role of carbohydrateSteve Elliott, Joan Egrie, Jeff Browne, et al.
Kidney International|May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factorSerafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitorsMike Frohn, Vellarkad Viswanadhan, Alexander J Pickrell, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2008
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluationChristopher M Tegley, Vellarkad N Viswanadhan, Kaustav Biswas, et al.
Nature Biotechnology|March 4, 2003
Enhancement of therapeutic protein in vivo activities through glycoengineeringSteve Elliott, Tony Lorenzini, Sheilah Asher, et al.
Cell Reports|January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative PhosphorylationYuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Journal of Medicinal Chemistry|October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical PropertiesMichael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental Hematology|December 14, 2004
Control of rHuEPO biological activity: the role of carbohydrateSteve Elliott, Joan Egrie, Jeff Browne, et al.
Kidney International|May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factorSerafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1alpha prolyl hydroxylase-2 inhibitorsMike Frohn, Vellarkad Viswanadhan, Alexander J Pickrell, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2008
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluationChristopher M Tegley, Vellarkad N Viswanadhan, Kaustav Biswas, et al.
Nature Biotechnology|March 4, 2003
Enhancement of therapeutic protein in vivo activities through glycoengineeringSteve Elliott, Tony Lorenzini, Sheilah Asher, et al.
Cell Reports|January 10, 2019
Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative PhosphorylationYuting Sun, Madhavi Bandi, Timothy Lofton, et al.
Journal of Medicinal Chemistry|October 29, 2020
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical PropertiesMichael J Soth, Kang Le, Maria Emilia Di Francesco, et al.
Pageof 1